What is NovoCure's change in AP?

NovoCure (NVCR) reported change in AP of -$5.12M in Q1 2026.

How has NovoCure's change in AP changed year-over-year?

NovoCure's change in AP increased by 68.8% year-over-year, from -$16.42M to -$5.12M.

What is the long-term trend for NovoCure's change in AP?

Over 4 years (2021 to 2025), NovoCure's change in AP has grown at a -9.1% compound annual growth rate (CAGR), from $27.78M to $18.96M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

NovoCure NVCR Change in AP

Change in AP at other companies

Boston ScientificBSX

-$512M-33.0%

MedtronicMDT

$123M-66.4%

Iovance Biotherapeutics, Inc.IOVA

$15.89M+674%

Nuvation BioNUVB

$12.96M+209%

Syndax PharmaceuticalsSNDX

-$5.74M-263%

ArriVent BioPharma, Inc.AVBP

$2.81M+382%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's change in AP?: NovoCure (NVCR) reported change in AP of -$5.12M in Q1 2026.
How has NovoCure's change in AP changed year-over-year?: NovoCure's change in AP increased by 68.8% year-over-year, from -$16.42M to -$5.12M.
What is the long-term trend for NovoCure's change in AP?: Over 4 years (2021 to 2025), NovoCure's change in AP has grown at a -9.1% compound annual growth rate (CAGR), from $27.78M to $18.96M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.